Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians
Main Authors: | Yoshihito Fujita, Nobuya Inagaki |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-11-01
|
Series: | Journal of Diabetes Investigation |
Online Access: | https://doi.org/10.1111/jdi.13150 |
Similar Items
-
Update on the impact of sodium-glucose cotransporter inhibitors in diabetic kidney disease progression
by: Ana Carolina Cruz Afonso Romano
Published: (2021) -
Cardiovascular effects of sodium glucose cotransporter 2 inhibitors
by: Santos Cavaiola T, et al.
Published: (2018-04-01) -
Inhibitors of sodium-glucose cotransporter 2: risk of ketoacidosis
by: T. M. Bukatina, et al.
Published: (2018-02-01) -
Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitor drugs: Assessment of safety in Fasting Diabetics
by: Muhammad Imran Hasan Khan, et al.
Published: (2021-03-01) -
Cardiovascular effects and mechanisms of sodium-glucose cotransporter-2 inhibitors
by: Fan Yang, et al.
Published: (2020-12-01)